New research assessing the efficacy of optical genome mapping (OGM) in a group of patients with acute leukemia has ...

Scientific Presentations and Posters: The number of presentations of OGM scientific content at the ECA conference has grown over recent years. In 2025, a total of 16 studies—including oral ...

Bionano Genomics and Greenwood Genetic Center have announced a study published in Genome Research, marking the first use of optical genome mapping (OGM) to explore the genetic factors behind neural ...

DUBLIN--(BUSINESS WIRE)--The "Optical Genome Mapping Market Size, Share & Trends Analysis Report, By Product (Instruments, Software), By Application (Structural Variant Detection, Genome Assembly), By ...

SAN DIEGO, May 02, 2025 (GLOBE NEWSWIRE) -- Bionano Laboratories, a wholly-owned subsidiary of Bionano Genomics, Inc. (BNGO) that offers CLIA-certified laboratory developed tests (LDTs) based on ...

SAN DIEGO, June 18, 2025 (GLOBE NEWSWIRE) -- Bionano Genomics (BNGO) recently participated in the European Society of Human Genetics (ESHG) conference held in Milan, Italy, from May 24-27, 2025. The ...

Baylor Genetics, a leading diagnostic genomics partner offering a full spectrum of clinically relevant genetic testing, today announced enhancements to its Whole Genome Sequencing (WGS) test with the ...

SAN DIEGO, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced highlights from Day 1 of the Bionano Symposium 2026 entitled Advancements in Hematologic Malignancies ...

Patients with epilepsy are affected by a brain disorder where nerve cells fail to signal properly, resulting in uncontrolled bursts of electrical activity or seizures. For the most part, epilepsy can ...